← Eichor
Study identifier: NCT06567470 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study With CIT-013 in RA Patients

Condition: Rheumatoid Arthritis  ·  Sponsor: Citryll BV

PhasePhase 2
Planned participants88
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if CIT-013 works to treat rheumatoid arthritis in adults. It will also learn about the safety of CIT-013. The main questions it aims to answer are: Does CIT-013 lower the disease activity of RA patients? What medical problems do participants have when receiving CIT-013? Researchers will compare CIT-013 to a placebo (a look-alike substance that contains no drug) to see if CIT-013 works to treat the symptoms of RA. Participants will: Take receive CIT-013 or placebo every other week for 6 weeks and 50 mg CIT-013 for 6 weeks Visit the clinic once every 2 weeks for checkups and tests Keep monitor their symptoms during this period

This description comes directly from the study's public registry record.

Talk to the study team

Leonie Middelink  ·  0613328444  ·  lmiddelink@citryll.com

Always discuss trial participation with your own doctor first.

Locations (24)

BE-02Antwerp, BelgiumWithdrawn
Site BE-01Leuven, BelgiumRecruiting
DE-04Bamberg, GermanyRecruiting
DE-05Berlin, GermanyRecruiting
DE-01München, GermanyRecruiting
DE-02München, GermanyRecruiting
DE-03Ratingen, GermanyWithdrawn
NL-02Amsterdam, NetherlandsWithdrawn
NL-05Leeuwarden, NetherlandsRecruiting
NL-04Leiden, NetherlandsWithdrawn
NL-03Nijmegen, NetherlandsNot Yet Recruiting
NL-01Rotterdam, NetherlandsRecruiting

+ 12 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06567470